Announced Mon, 24 Aug · 14:05 IST
Post Offer Advertisement published for Parmax Pharma open offer
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
—1-day move
₹129.90
prior close
₹131.15
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
—+0.0+0.0+0.0————+2.0—+4.0———
Up moveDown movePending
AI summary
Fedex Securities, Manager to the Offer, submitted a Post Offer Advertisement to BSE for the open offer to acquire up to 23,46,250 equity shares (26% of expanded voting capital) of Parmax Pharma from public shareholders. The advertisement dated August 22, 2026 was published on August 24, 2026 in Financial Express, Jansatta, and Mumbai Lakshdeep newspapers.
Likely market impact
Informational compliance filing. Confirms completion of open offer process for acquiring 26% stake from public shareholders. No shareholder action required.